Kessler Investment Group LLC Purchases Shares of 4,795 Celcuity Inc (CELC)

Share on StockTwits

Kessler Investment Group LLC purchased a new stake in shares of Celcuity Inc (NASDAQ:CELC) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 4,795 shares of the company’s stock, valued at approximately $115,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Acadian Asset Management LLC raised its holdings in shares of Celcuity by 58.3% during the third quarter. Acadian Asset Management LLC now owns 4,797 shares of the company’s stock valued at $138,000 after purchasing an additional 1,766 shares during the period. Teachers Advisors LLC acquired a new position in shares of Celcuity during the third quarter valued at about $207,000. California Public Employees Retirement System acquired a new position in shares of Celcuity during the second quarter valued at about $248,000. Schwab Charles Investment Management Inc. acquired a new position in shares of Celcuity during the second quarter valued at about $271,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Celcuity during the second quarter valued at about $291,000. 15.24% of the stock is currently owned by institutional investors and hedge funds.

Shares of CELC traded up $0.15 on Friday, reaching $22.80. The company’s stock had a trading volume of 3 shares, compared to its average volume of 11,271. Celcuity Inc has a twelve month low of $13.16 and a twelve month high of $31.00. The firm has a market capitalization of $248.29 million, a PE ratio of -29.49 and a beta of 0.77.

Celcuity (NASDAQ:CELC) last posted its earnings results on Tuesday, November 13th. The company reported ($0.15) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.18) by $0.03. Sell-side analysts predict that Celcuity Inc will post -0.76 earnings per share for the current fiscal year.

CELC has been the topic of several research reports. Craig Hallum upped their price objective on shares of Celcuity from $30.00 to $35.00 and gave the company a “buy” rating in a report on Wednesday, November 14th. HC Wainwright set a $36.00 target price on shares of Celcuity and gave the stock a “buy” rating in a report on Monday, December 10th.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Week Herald and is the sole property of of Week Herald. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at

About Celcuity

Celcuity Inc, a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the response rates of cancer patients treated with targeted therapies in the United States. The company is developing CELx tests to diagnose two new sub-types of HER2-negative breast cancer.

Featured Story: Different Types of Derivatives

Want to see what other hedge funds are holding CELC? Visit to get the latest 13F filings and insider trades for Celcuity Inc (NASDAQ:CELC).

Institutional Ownership by Quarter for Celcuity (NASDAQ:CELC)

Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with's FREE daily email newsletter.

Leave a Reply